| Absorption |
| Blood-Brain Barrier | BBB- | 0.9476 |
| Human Intestinal Absorption | HIA+ | 0.9908 |
| Caco-2 Permeability | Caco2- | 0.5196 |
| P-glycoprotein Substrate | Non-substrate | 0.6652 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9818 |
| Non-inhibitor | 0.9946 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9341 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5678 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7936 |
| CYP450 2D6 Substrate | Non-substrate | 0.7668 |
| CYP450 3A4 Substrate | Non-substrate | 0.7456 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9466 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9789 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9294 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9229 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8329 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9705 |
| Non-inhibitor | 0.9117 |
| AMES Toxicity | AMES toxic | 0.6857 |
| Carcinogens | Non-carcinogens | 0.8948 |
| Fish Toxicity | Low FHMT | 0.5212 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9039 |
| Honey Bee Toxicity | Low HBT | 0.5657 |
| Biodegradation | Not ready biodegradable | 0.7553 |
| Acute Oral Toxicity | III | 0.6255 |
| Carcinogenicity (Three-class) | Non-required | 0.5893 |